New CEO for Atacama Labs Oy

11-Feb-2010 - Finland
As of January 2010 Mr.Steffen Mittwich has been appointed as new CEO for Atacama Labs Oy, a Finnish specialty pharmaceutical company, which has developed a unique pneumatic dry granulation method called PDG Technology(TM). Mr. Mittwich is based in Geneva, Switzerland. In his new role, Mr. Mittwich will focus on building up of the company and establishing partnerships with galenic development and contract manufacturing partners. In addition, his extensive experience of pharmaceutical industry will be helpful in establishing client cooperation and joint ventures. Mr. Mittwich has worked in pharma industry since 1992 and has held several management positions within major European and international pharmaceutical companies, such as Sanofi-aventis, Aventis Pharma, and Pfizer. His latest position at Sanofi-aventis was Regional Business Director and CEO Winthrop Pharmaceuticals. Steffen Mittwich is Industrial Economics Engineer from the TechnicalUniversity of Karlsruhe, Germany.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances